Pharma Bio World – The Cold Chain Of The Future
In today’s continuously volatile market, with customers demanding greater efficiencies at increasingly lower costs, logistics providers are constantly searching for new technologies and processes that will not only improve operations but help give their business a competitive edge. With the cold chain logistics market for the pharmaceutical industry set to grow by USD 9.37 billion from 2020 to 2025, according to Technavio, specialist freight providers must be forward thinking to stay ahead and make its processes as efficient as possible.
Effective temperature sensitive solutions in the pharmaceutical supply chain has increased hugely in recent years. With a growing prominence for personalised medicines, we are now beginning to see the advancements of precision therapies in the pharmaceutical cold chain industry. There is no longer a “one-size-fits-all” approach to medical practice. Instead, we’re seeing a shift towards bio-specific treatments, tailored to a particular individual’s needs based on their genetic material.
And, with manufacturing adjusting to smaller batch, precision medicines, the vendors and outsourcing partners must adapt too as the need for transparent, closely controlled global chains demands rise.
For full article please visit: 20th Anniversary – Jasubhai Media Pvt Ltd
Authored by Nick Gilmore Head of Global Sales and Marketing at Tower Cold Chain